[1] Anastasiadi Z, Lianos G D, Ignatiadou E, Harissis H V, Mitsis M. Breast cancer in young women: an overview. Updates Surg, 2017, 69(3): 313-7.PMID:28260181. doi:10.1007/s13304-017-0424-1
[2] Harbeck N, Gnant M. Breast cancer. Lancet, 2017, 389(10074): 1134-50.PMID:27865536. doi:10.1016/S0140-6736(16)31891-8
[3] Li T, Mello-Thoms C, Brennan P C. Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence. Breast Cancer Res Treat, 2016, 159(3): 395-406.PMID:27562585. doi:10.1007/s10549-016-3947-0
[4] Waks A G, Winer E P. Breast Cancer Treatment: A Review. JAMA, 2019, 321(3): 288-300.PMID:30667505. doi:10.1001/jama.2018.19323
[5] Qadir M I, Faheem A. miRNA: A Diagnostic and Therapeutic Tool for Pancreatic Cancer. Crit Rev Eukaryot Gene Expr, 2017, 27(3): 197-204.PMID:29199604. doi:10.1615/CritRevEukaryotGeneExpr.2017019494
[6] Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, Song J, Li Z, Zhang Z, Yuan W. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer, 2018, 17(1): 147-.PMID:30309355. doi:10.1186/s12943-018-0897-7
[7] Vishnoi A, Rani S. MiRNA Biogenesis and Regulation of Diseases: An Overview. Methods Mol Biol, 2017, 1509(1-10.PMID:27826912. doi:10.1007/978-1-4939-6524-3_1
[8] Zou Q, Tang Q, Pan Y, Wang X, Dong X, Liang Z, Huang D. MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1. Exp Ther Med, 2017, 14(2): 1009-16.PMID:28781618. doi:10.3892/etm.2017.4590
[9] Nassar F J, Nasr R, Talhouk R. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction. Pharmacol Ther, 2017, 172(34-49.PMID:27916656. doi:10.1016/j.pharmthera.2016.11.012
[10] Bahena-Ocampo I, Espinosa M, Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A, Garcia-Lopez P, Maldonado V, Melendez-Zajgla J. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation. EMBO Rep, 2016, 17(7): 1081-.PMID:27371635. doi:10.15252/embr.201642700
[11] Damiano V, Brisotto G, Borgna S, Di Gennaro A, Armellin M, Perin T, Guardascione M, Maestro R, Santarosa M. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1. Genes Chromosomes Cancer, 2017, 56(2): 147-58.PMID:27717206. doi:10.1002/gcc.22422
[12] Shen G, Rong X, Zhao J, Yang X, Li H, Jiang H, Zhou Q, Ji T, Huang S, Zhang J, Jia H. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. Carcinogenesis, 2014, 35(12): 2748-55.PMID:25280563. doi:10.1093/carcin/bgu208
[13] Sirotkin A V, Lauková M, Ovcharenko D, Brenaut P, Mlyncek M. Identification of microRNAs controlling human ovarian cell proliferation and apoptosis. J Cell Physiol, 2010, 223(1): 49-56.PMID:20039279. doi:10.1002/jcp.21999
[14] Merino Bonilla J A, Torres Tabanera M, Ros Mendoza L H. Breast cancer in the 21st century: from early detection to new therapies. Radiologia, 2017, 59(5): 368-79.PMID:28712528. doi:10.1016/j.rx.2017.06.003
[15] Inns J, James V. Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease. Breast, 2015, 24(4): 364-9.PMID:25957467. doi:10.1016/j.breast.2015.04.001
[16] Serpico D, Molino L, Di Cosimo S. microRNAs in breast cancer development and treatment. Cancer Treat Rev, 2014, 40(5): 595-604.PMID:24286642. doi:10.1016/j.ctrv.2013.11.002
[17] Hamfjord J, Stangeland A M, Hughes T, Skrede M L, Tveit K M, Ikdahl T, Kure E H. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One, 2012, 7(4): e34150-e.PMID:22529906. doi:10.1371/journal.pone.0034150
[18] Honeywell D R, Cabrita M A, Zhao H, Dimitroulakos J, Addison C L. miR-105 inhibits prostate tumour growth by suppressing CDK6 levels. PLoS One, 2013, 8(8): e70515-e.PMID:23950948. doi:10.1371/journal.pone.0070515
[19] Witkos T M, Lowe M. Recognition and tethering of transport vesicles at the Golgi apparatus. Curr Opin Cell Biol, 2017, 47(16-23.PMID:28237810. doi:10.1016/j.ceb.2017.02.003
[20] Bai Y, Cui X, Gao D, Wang Y, Wang B, Wang W. Golgi integral membrane protein 4 manipulates cellular proliferation, apoptosis, and cell cycle in human head and neck cancer. Biosci Rep, 2018, 38(4): BSR20180454.PMID:30068697. doi:10.1042/BSR20180454